The potential role for phage therapy for genetic modification of cutaneous diseases

Area of Science:

• Microbiology
• Virology
• Dermatology

Background:

• Antimicrobial resistance is a growing global health crisis, leading to significant mortality.
• Existing antimicrobials face increasing bacterial resistance, necessitating novel therapeutic strategies.
• Bacteriophages (phages) are viruses that infect bacteria and represent a potential alternative to antibiotics.

Purpose of the Study:

• To explore the potential of bacteriophage therapy as a solution to antimicrobial resistance.
• To review the application of bacteriophages in treating bacterial infections, particularly in dermatological conditions.
• To highlight the benefits of phage therapy for genodermatoses and related skin infections.

Main Methods:

• Review of existing literature on bacteriophage therapy and antimicrobial resistance.
• Analysis of phage-bacterial interactions and mechanisms of action.
• Case study review of phage therapy in Netherton syndrome and potential applications in acne vulgaris and other genodermatoses.

Main Results:

• Bacteriophages can effectively target and lyse bacteria, including antibiotic-resistant strains.
• Phage therapy has shown promise in managing Staphylococcus aureus infections associated with Netherton syndrome.
• Emerging data suggest efficacy of phage therapy against Cutibacterium acnes in acne vulgaris and related genetic disorders.

Conclusions:

• Bacteriophage therapy presents a viable alternative to conventional antibiotics for treating resistant bacterial infections.
• Phage therapy holds significant potential for managing genodermatoses and other skin conditions characterized by recurrent bacterial infections.
• Further research and clinical trials are warranted to fully establish the role of bacteriophages in modern medicine.